Literature DB >> 22082466

A challenging case: Symmetrical drug related intertriginous and flexural exanthem, fixed drug eruption, or both?

Esen Ozkaya1, Goncagül Babuna.   

Abstract

We herein report a 12-year-old boy with amoxicillin-induced, recurrent, site-specific, symmetrical, sharply demarcated reddish plaques on the buttocks and the major flexural and intertriginous areas. The lesions resolved with topical corticosteroids, leaving hyperpigmentation. Histopathology showed nonspecific features of inflammation and dermal melanophages. Amoxicillin was the probable inducer based on oral provocation test with Amoksina(®) tablet, however patch testing with amoxicillin on previously affected and unaffected skin remained negative. The diagnosis was challenging because of the overlapping features of symmetrical drug-related intertriginous and flexural exanthema and fixed drug eruption. This one represents a unique and challenging one with overlapping clinical features of symmetrical drug-related intertriginous and flexural exanthem (SDRIFE) and fixed drug eruption (FDE). We discuss the possible immunopathogenetic mechanisms leading to the simultaneous occurrence of different phenotypes of drug eruption in the same patient.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22082466     DOI: 10.1111/j.1525-1470.2011.01656.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  2 in total

1.  Co-occurrence of Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE) and Pigmented Fixed Drug Eruption (FDE) in a Single Patient Due to Doxycycline: A Case Report.

Authors:  Kananbala Sahu; Chandra S Sirka; Swetalina Pradhan; Arpita N Rout
Journal:  Indian Dermatol Online J       Date:  2020-01-13

2.  Systemic drug-related intertriginous and flexural exanthema from radio contrast media: A series of 3 cases.

Authors:  Thy Huynh; Lauren C Hughey; Kristopher McKay; Caitlin Carney; Naveed Sami
Journal:  JAAD Case Rep       Date:  2015-05-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.